CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $603 | -99.9% | 103,300 | -1.4% | 0.03% | -14.7% |
| Q3 2022 | $702,000 | +59.2% | 104,800 | 0.0% | 0.03% | +78.9% |
| Q2 2022 | $441,000 | +14.5% | 104,800 | +228.5% | 0.02% | +137.5% |
| Q1 2019 | $385,000 | -76.2% | 31,900 | -75.3% | 0.01% | -77.1% |
| Q4 2018 | $1,621,000 | +0.3% | 129,206 | +18.6% | 0.04% | +20.7% |
| Q3 2018 | $1,616,000 | -9.3% | 108,912 | +2.8% | 0.03% | -6.5% |
| Q2 2018 | $1,782,000 | -28.4% | 105,942 | -2.5% | 0.03% | -27.9% |
| Q1 2018 | $2,489,000 | +572.7% | 108,652 | +658.8% | 0.04% | +616.7% |
| Q4 2017 | $370,000 | – | 14,318 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |